Drug Shortage Report for SUBLINOX

Last updated on 2019-10-17 History
Report ID 96014
Drug Identification Number 02391678
Brand name SUBLINOX
Common or Proper name SUBLINOX
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) ZOLPIDEM TARTRATE
Strength(s) 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration SUBLINGUAL
Packaging size n/a
ATC code N05CF
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-10-03
Estimated end date
Actual end date 2019-10-14
Shortage status Resolved
Updated date 2019-10-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-10-17 French Compare
v3 2019-10-17 English Compare
v2 2019-10-10 French Compare
v1 2019-10-10 English Compare

Showing 1 to 4 of 4